Sigma-Aldrich

HUB Organoids is a biotechnology company that creates and utilizes patient-derived organ models, known as organoids, to advance drug development and personalized medicine. They offer services such as preclinical testing, custom organoid model development, and licensing of their proprietary technology. By maintaining living organoid biobanks, HUB Organoids enables other biotech businesses to access a comprehensive range of services under one roof, facilitating drug discovery, predictive diagnostics, and clinical trial support.

Mirus Bio specializes in providing gene transfer technologies for the pharmaceutical industry, focusing on the development of innovative nucleic acid-based solutions. The company has developed a proprietary RNAi (Ribonucleic Acid Interference) delivery platform that equips life scientists with advanced tools for various applications, including gene expression, biotherapeutic protein production, virus manufacturing, and genome editing. Through its commitment to innovation, Mirus Bio aims to enhance the capabilities of researchers and contribute to advancements in biotechnology.

Erbi Biosystems, Inc. specializes in developing innovative microbioreactor technology solutions aimed at automating the study of microorganisms. The company offers a range of products, including microbioreactor devices, disposable fluid sources, control modules, and system software. These systems are designed to streamline and standardize complex cell culture processes, facilitating basic research, bioprocess characterization, and optimization while reducing variability between experiments. Founded in 2006 and based in Woburn, Massachusetts, Erbi Biosystems was previously known as Pharyx, Inc. before rebranding in January 2019. The company's microfluidic bioprocess instrumentation is intended to enhance research capabilities, particularly in areas such as cell-based cancer immunotherapies and parallel anaerobic fermentations.

The MAST platform is an automated, aseptic bioreactor sampling system designed to advance bioprocessing capabilities for more efficient and cost-effective drug manufacturing.

AmpTec is an international provider of RNA technology products, specializing in RNA isolation, mRNA amplification kits, and the production of synthetic long RNAs and DNAs. The company focuses on polymerase chain reaction-based technologies for mRNA manufacturing, which are essential for developing therapeutics. In addition to its core offerings, AmpTec also manufactures lipids and provides customized long RNAs and DNAs for in vitro diagnostics. The company is dedicated to engaging directly with life science industries and academic research institutions globally, offering on-site technical support to enhance customer interactions.

FloDesign Sonics specializes in innovative acoustic technology aimed at revolutionizing separations and filtration processes across various industries. The company utilizes advanced 3D acoustic standing waves to capture, separate, and purify mixtures without relying on physical membranes, chemicals, or centrifugation. This proprietary technology has significant applications in life sciences, particularly in the bioprocess separations sector for the manufacturing of life-saving biopharmaceuticals, as well as in oil and gas, food and beverage, and industrial processing markets. By offering a more efficient and sustainable method of separation and filtration, FloDesign Sonics is positioned to make a notable impact on these industries.

Cell Marque is a manufacturer based in Rocklin, California, specializing in the development and production of antibody reagents for immunohistochemistry applications. The company offers a diverse and innovative portfolio of antibodies suitable for both frozen and formalin-fixed, paraffin-embedded (FFPE) tissue sections. Focused primarily on in vitro diagnostics, Cell Marque has expanded its offerings with over 70 additional antibodies introduced between 2008 and 2009, aiming to enhance the clinical market's capabilities. In addition to antibodies, the company designs and manufactures pretreatments, chromogens, ancillary reagents, and laboratory equipment, ensuring comprehensive support for healthcare providers in delivering high-quality patient care.

ChemNavigator.com, Inc. is a provider of tools and services aimed at assisting scientists in the identification and procurement of chemical compounds essential for drug discovery and agrochemical research. Founded in 1999 and based in San Diego, California, the company offers a comprehensive database that includes a wide array of chemical products, from drug-like compounds for molecular screening to synthetic building blocks for chemical synthesis. This database facilitates chemical data analysis and compound selection, thereby enabling researchers in medicinal, computational, and synthetic chemistry, as well as professionals in chemical procurement, to efficiently select and acquire novel chemical products for their research needs. As of August 2009, ChemNavigator operates as a subsidiary of Sigma-Aldrich Corporation.